The purpose of this core component is to provide expertise and technical support to the design and execution of experimental approaches utilizing flow cytometry analysis and physical separation techniques to address basic and applied research questions in the area of HIV-immune cell interactions. The core facility will provide technical resources for immune cell phenotyping, physical separation and isolation of cell phenotypes, analysis of cell activation functions, and analysis of molecular, expression vector constructs. The equipment to perform these functions includes a Becton-Dickinson FACStar Plus cell sorter with a fifth debtor for 3- color analysis, and a Coulter Elite cell sorter with dual lasers plus a UV laser for calcium flux and cellular DNA analyses. Support personnel include a highly-trained and experienced technician for preparation and/or separation, and antibody staining of cell samples. The Core Director, who is experienced in flow cytometry methodology and experimental design, will provide consultation and research direction to investigator users of the facility. The major goal of this basic science component is to provide the intellectual environment and the material resources to enable junior investigators to apply flow cytometry technology to appropriate research projects and to encourage innovative pilot studies by more established investigators.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
1P30AI036214-01
Application #
3747627
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Eren, Kemal; Murrell, Ben (2018) RIFRAF: a frame-resolving consensus algorithm. Bioinformatics 34:3817-3824
de Almeida, Sérgio Monteiro; Ribeiro, Clea E; Rotta, Indianara et al. (2018) Biomarkers of neuronal injury and amyloid metabolism in the cerebrospinal fluid of patients infected with HIV-1 subtypes B and C. J Neurovirol 24:28-40
Martin, Thomas C S; Rauch, Andri; Salazar-Vizcaya, Luisa et al. (2018) Understanding and Addressing Hepatitis C Virus Reinfection Among Men Who Have Sex with Men. Infect Dis Clin North Am 32:395-405
Jenks, Jeffrey D; Hoenigl, Martin (2018) Treatment of Aspergillosis. J Fungi (Basel) 4:
Stecher, M; Chaillon, A; Eis-Hübinger, A M et al. (2018) Pretreatment human immunodeficiency virus type 1 (HIV-1) drug resistance in transmission clusters of the Cologne-Bonn region, Germany. Clin Microbiol Infect :
Lim, Aaron G; Qureshi, Huma; Mahmood, Hassan et al. (2018) Curbing the hepatitis C virus epidemic in Pakistan: the impact of scaling up treatment and prevention for achieving elimination. Int J Epidemiol 47:550-560
Lin, Timothy C; Burton, Brittany N; Barleben, Andrew et al. (2018) Association of HIV infection with age and symptomatic carotid atherosclerotic disease at the time of carotid intervention in the United States. Vasc Med 23:467-475
Singh, Rajendra; Stoneham, Charlotte; Lim, Christopher et al. (2018) Phosphoserine acidic cluster motifs bind distinct basic regions on the ? subunits of clathrin adaptor protein complexes. J Biol Chem 293:15678-15690
Guise, Andy; Melo, Jason; Mittal, Maria Luisa et al. (2018) A fragmented code: The moral and structural context for providing assistance with injection drug use initiation in San Diego, USA. Int J Drug Policy 55:51-60
Bekker, Linda-Gail; Alleyne, George; Baral, Stefan et al. (2018) Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission. Lancet 392:312-358

Showing the most recent 10 out of 921 publications